-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $337

Benzinga·10/09/2026 12:24:05
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $330 to $337.